-
Mashup Score: 1Asian Americans, Native Hawaiian, and Other Pacific Islanders - 6 hour(s) ago
Asian Americans, Native Hawaiian, and Other Pacific Islanders
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Oncology Regulatory Affairs and Policy Program - 1 day(s) ago
OCE Oncology Regulatory Affairs and Policy Program
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
May 22, 2024: Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting Announcement
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11FDA OCE expert presentations at public meetings - 2 day(s) ago
OCE experts regularly join colleagues to participate in major conferences.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 16Division of Oncology 2 (DO2) - 2 day(s) ago
The Division of Oncology 2 (DO2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas: gastrointestinal, lung, and head and neck cancers; neuro-oncology, rare cancers, pediatric
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Oncology Center of Excellence Guidance Documents - 2 day(s) ago
Recently added guidance documents regarding oncology and malignant hematology
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
The U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) Patient-Focused Drug Development (PFDD) program welcomes you to the Clinical Outcome Assessment in Cancer Clinical Trials (COA-CCT) 9th annual workshop.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20
On May 15, 2024, the FDA granted accelerated approval to lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) for adults with follicular lymphoma.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5OCE ENGAGE: A Project Community Newsletter - 3 day(s) ago
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20
On May 15, 2024, the FDA granted accelerated approval to lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) for adults with follicular lymphoma.
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
Project ASIATICA is an OCE initiative to bring focus and awareness to Asian American, Native Hawaiian, and Other Pacific Islander (AA & NHPI) patients with cancer (this web page provides translations into 10 languages). #OCEProjectASIATICA https://t.co/ILIExlogL5